These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31903686)

  • 1. Role of PCSK9 in the course of ejection fraction change after ST-segment elevation myocardial infarction: a pilot study.
    Miñana G; Núñez J; Bayés-Genís A; Revuelta-López E; Ríos-Navarro C; Núñez E; Chorro FJ; López-Lereu MP; Monmeneu JV; Lupón J; Sanchis J; Bodí V
    ESC Heart Fail; 2020 Feb; 7(1):117-122. PubMed ID: 31903686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term efficacy of angiotensin receptor-neprilysin inhibitor treatment in patients with ST-segment elevation myocardial infarction with reduced ejection fraction after primary percutaneous coronary intervention: a propensity score matching study.
    Zhang Q; Qiao B; Han Y; Sun S; Wang B; Wei S
    BMC Cardiovasc Disord; 2022 Nov; 22(1):463. PubMed ID: 36333668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Serum Secreted Frizzled-Related Protein 5 Levels Associates with Early Improvement of Cardiac Function Following ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention.
    Du Y; Zhao Y; Zhu Y; Hu C; Zhang J; Ji Q; Liu W; Han H; Yang L; Zhang D; Tong S; Wang Z; Guo Y; Liu X; Zhou Y
    J Atheroscler Thromb; 2019 Oct; 26(10):868-878. PubMed ID: 30773518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant association between admission serum monocyte chemoattractant protein-1 and early changes in myocardial function in patients with first ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
    Zhu Y; Hu C; Du Y; Zhang J; Liu J; Han H; Zhao Y
    BMC Cardiovasc Disord; 2019 May; 19(1):107. PubMed ID: 31077149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of early PCSK9 inhibitor treatment on heart after percutaneous coronary intervention in patients with STEMI: Design and rationale of the PERFECT II trial.
    Xia J; Wang X; Zhou J; Wang D; Pang Y; Xu X; Sang Z; Zhang Y; Zhang J; Wu S; Xiao Z; Hou L
    Front Cardiovasc Med; 2022; 9():1009674. PubMed ID: 36211588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contemporary value of peak creatine kinase-MB after ST-segment elevation myocardial infarction above other clinical and angiographic characteristics in predicting infarct size, left ventricular ejection fraction, and mortality.
    Hartman MHT; Eppinga RN; Vlaar PJJ; Lexis CPH; Lipsic E; Haeck JDE; van Veldhuisen DJ; van der Horst ICC; van der Harst P
    Clin Cardiol; 2017 May; 40(5):322-328. PubMed ID: 28026027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of left ventricular ejection fraction recovery in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: analysis of an 11-year all-comers registry.
    Otero-García O; Cid-Álvarez AB; Juskova M; Álvarez-Álvarez B; Tasende-Rey P; Gude-Sampedro F; García-Acuña JM; Agra-Bermejo R; López-Otero D; Sanmartín-Pena JC; Martínez-Monzonís A; Trillo-Nouche R; González-Juanatey JR
    Eur Heart J Acute Cardiovasc Care; 2021 Oct; 10(8):898-908. PubMed ID: 34327531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined assessment of left ventricular end-diastolic pressure and ejection fraction by left ventriculography predicts long-term outcomes of patients with ST-segment elevation myocardial infarction.
    Saito D; Nakanishi R; Watanabe I; Yabe T; Okubo R; Amano H; Toda M; Ikeda T
    Heart Vessels; 2018 May; 33(5):453-461. PubMed ID: 29143103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ST2 and left ventricular remodeling after ST-segment elevation myocardial infarction: A cardiac magnetic resonance study.
    Miñana G; Núñez J; Bayés-Genís A; Revuelta-López E; Ríos-Navarro C; Núñez E; Chorro FJ; López-Lereu MP; Monmeneu JV; Lupón J; Bodí V
    Int J Cardiol; 2018 Nov; 270():336-342. PubMed ID: 29954670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between TRAIL and Left Ventricular Ejection Fraction in Patients with ST-Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention.
    Teringova E; Kozel M; Knot J; Kocka V; Benesova K; Tousek P
    Biomed Res Int; 2018; 2018():3709084. PubMed ID: 30112383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem-cell therapy in ST-segment elevation myocardial infarction with reduced ejection fraction: A multicenter, double-blind randomized trial.
    Nicolau JC; Furtado RHM; Silva SA; Rochitte CE; Rassi A; Moraes JBMC; Quintella E; Costantini CR; Korman APM; Mattos MA; Castello HJ; Caixeta A; Dohmann HFR; de Carvalho ACC;
    Clin Cardiol; 2018 Mar; 41(3):392-399. PubMed ID: 29569254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sub-acute cardiac magnetic resonance to predict irreversible reduction in left ventricular ejection fraction after ST-segment elevation myocardial infarction: A DANAMI-3 sub-study.
    Alzuhairi KS; Lønborg J; Ahtarovski KA; Nepper-Christensen L; Kyhl K; Lassen JF; Sørensen R; Joshi F; Ghotbi AA; Schoos M; Goransson C; Bertelsen L; Helqvist S; Holmvang L; Jørgensen E; Pedersen F; Tilsted HH; Høfsten D; Køber L; Kelbæk H; Vejlstrup N; Engstrøm T
    Int J Cardiol; 2020 Feb; 301():215-219. PubMed ID: 31748187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Implications of Global Longitudinal Strain by Feature-Tracking Cardiac Magnetic Resonance in ST-Elevation Myocardial Infarction.
    Reindl M; Tiller C; Holzknecht M; Lechner I; Beck A; Plappert D; Gorzala M; Pamminger M; Mayr A; Klug G; Bauer A; Metzler B; Reinstadler SJ
    Circ Cardiovasc Imaging; 2019 Nov; 12(11):e009404. PubMed ID: 31679391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Stratification of Patients With ST-Segment-Elevation Myocardial Infarction (PROSPECT): A Cardiac Magnetic Resonance Study.
    Pontone G; Guaricci AI; Andreini D; Ferro G; Guglielmo M; Baggiano A; Fusini L; Muscogiuri G; Lorenzoni V; Mushtaq S; Conte E; Annoni A; Formenti A; Mancini ME; Carità P; Verdecchia M; Pica S; Fazzari F; Cosentino N; Marenzi G; Rabbat MG; Agostoni P; Bartorelli AL; Pepi M; Masci PG
    Circ Cardiovasc Imaging; 2017 Nov; 10(11):. PubMed ID: 29146587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peri-event plasma PCSK9 and hsCRP after an acute myocardial infarction correlate with early deterioration of left ventricular ejection fraction: a cohort study.
    Silva-Bermúdez LS; Vargas-Villanueva A; Sánchez-Vallejo CA; Palacio AC; Buitrago AF; Mendivil CO
    Lipids Health Dis; 2022 Jul; 21(1):61. PubMed ID: 35864531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-Dependent Change in Omentin-1 Level Correlated with Early Improvement of Myocardial Function in Patients with First Anterior ST-Segment Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention.
    Zhu Y; Hu C; Du Y; Zhang J; Liu J; Cheng G; Han H; Zhao Y
    J Atheroscler Thromb; 2019 Oct; 26(10):856-867. PubMed ID: 30853697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated echocardiography after first ever ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention--is it necessary?
    Søholm H; Lønborg J; Andersen MJ; Vejlstrup N; Engstrøm T; Møller JE; Hassager C
    Eur Heart J Acute Cardiovasc Care; 2015 Dec; 4(6):528-36. PubMed ID: 25318482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a prognostic model for predicting post-discharge mortality risk in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI).
    Zhang L; Liu Z; Zhu Y; Wu M; Huang H; Yang W; Peng K; Zeng J
    J Cardiothorac Surg; 2024 Mar; 19(1):163. PubMed ID: 38555468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.
    Ezekowitz JA; Armstrong PW; Granger CB; Theroux P; Stebbins A; Kim RJ; Patel MR
    Am Heart J; 2010 Aug; 160(2):272-8. PubMed ID: 20691832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Guideline-Based Therapy on Left Ventricular Systolic Function Recovery After ST-Segment Elevation Myocardial Infarction.
    Abou R; Leung M; Goedemans L; Hoogslag GE; Schalij MJ; Marsan NA; Bax JJ; Delgado V
    Am J Cardiol; 2018 Nov; 122(10):1591-1597. PubMed ID: 30213383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.